FDA staff voices concern about lorcaserin's safety and efficacy

09/14/2010 | Google

FDA reviewers said Arena Pharmaceutical's weight-loss drug lorcaserin meets the agency's efficacy standards "by a slim margin" and voiced concern about adverse effects. An advisory panel is scheduled Thursday to review the treatment.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC